Abacus Medicine Pharmaceuticals ApS: Financial statements 2018
CVR: 39192063
Source: annual report 2018, Danish Business Authority
21/12/2017 – 31/12/2018
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -61,772 and a net result of DKK 860,434. Equity in the 2018 report amounted to DKK 15,336,184. The solvency ratio was 71.2%.
- Gross Profit
- DKK -61,772
- Profit/Loss
- DKK 860,434
- Equity
- DKK 15,336,184
- Total Assets
- DKK 21,533,789
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.